Susan M McCurry1, Susan M Shortreed2, Michael Von Korff2, Benjamin H Balderson2, Laura D Baker3, Bruce D Rybarczyk4, Michael V Vitiello5. 1. Department of Psychosocial and Community Health, University of Washington School of Nursing, Seattle, WA. 2. Group Health Research Institute, Seattle, WA. 3. Department of Internal Medicine and Epidemiology, Wake Forest University School of Medicine, Winston-Salem, NC. 4. Department of Psychology, Virginia Commonwealth University, Richmond, VA. 5. Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, WA.
Abstract
STUDY OBJECTIVES: Evaluate long-term effects of group interventions on sleep and pain outcomes in a primary care population of older adults with osteoarthritis pain and sleep disturbance. DESIGN: Double-blind, cluster-randomized controlled trial with 18-mo follow-up. SETTING: Group Health and University of Washington, Seattle, WA, from 2009 to 2011. PARTICIPANTS: Three hundred sixty-seven adults age 60 y and older, with osteoarthritis pain and insomnia symptoms. INTERVENTIONS: Six weekly sessions of group cognitive behavioral therapy for insomnia and pain (CBT-PI), pain alone (CBT-P), and education-only control (EOC) delivered in patients' primary care clinics. MEASUREMENTS AND RESULTS: There were no significant differences between treatment groups in sleep outcomes at 18 mo. This is a change from published significant 9-mo follow-up results for insomnia severity (Insomnia Severity Index) and sleep efficiency. There were no significant treatment differences in pain at either follow-up. Post hoc analyses of participants with greater insomnia and pain severity at baseline (n = 98) showed significant (P = 0.01) 18-mo reductions in pain comparing CBT-PI versus CBT-P (adjusted mean difference [AMD] = -1.29 [95% confidence interval (CI): -2.24,-0.33]). Moderate, albeit nonsignificant, CBT-PI versus EOC treatment effects for insomnia severity (AMD = -1.43 [95% CI: -4.71, 1.86]) and sleep efficiency (AMD = 2.50 [95% CI: -5.04, 10.05]) were also observed. Possible trial design and methodological considerations that may have affected results are discussed. CONCLUSIONS: Results suggest patients with higher levels of comorbid pain and insomnia may be most likely to experience sustained benefit from cognitive behavioral therapy interventions over time, and inclusion of insomnia treatment may yield more clinically meaningful improvements than cognitive behavioral therapy for pain alone. TRIAL REGISTRATION: clinicaltrials.gov identifier: NCT01142349.
RCT Entities:
STUDY OBJECTIVES: Evaluate long-term effects of group interventions on sleep and pain outcomes in a primary care population of older adults with osteoarthritis pain and sleep disturbance. DESIGN: Double-blind, cluster-randomized controlled trial with 18-mo follow-up. SETTING: Group Health and University of Washington, Seattle, WA, from 2009 to 2011. PARTICIPANTS: Three hundred sixty-seven adults age 60 y and older, with osteoarthritis pain and insomnia symptoms. INTERVENTIONS: Six weekly sessions of group cognitive behavioral therapy for insomnia and pain (CBT-PI), pain alone (CBT-P), and education-only control (EOC) delivered in patients' primary care clinics. MEASUREMENTS AND RESULTS: There were no significant differences between treatment groups in sleep outcomes at 18 mo. This is a change from published significant 9-mo follow-up results for insomnia severity (Insomnia Severity Index) and sleep efficiency. There were no significant treatment differences in pain at either follow-up. Post hoc analyses of participants with greater insomnia and pain severity at baseline (n = 98) showed significant (P = 0.01) 18-mo reductions in pain comparing CBT-PI versus CBT-P (adjusted mean difference [AMD] = -1.29 [95% confidence interval (CI): -2.24,-0.33]). Moderate, albeit nonsignificant, CBT-PI versus EOC treatment effects for insomnia severity (AMD = -1.43 [95% CI: -4.71, 1.86]) and sleep efficiency (AMD = 2.50 [95% CI: -5.04, 10.05]) were also observed. Possible trial design and methodological considerations that may have affected results are discussed. CONCLUSIONS: Results suggest patients with higher levels of comorbid pain and insomnia may be most likely to experience sustained benefit from cognitive behavioral therapy interventions over time, and inclusion of insomnia treatment may yield more clinically meaningful improvements than cognitive behavioral therapy for pain alone. TRIAL REGISTRATION: clinicaltrials.gov identifier: NCT01142349.
Authors: David Moher; Sally Hopewell; Kenneth F Schulz; Victor Montori; Peter C Gøtzsche; P J Devereaux; Diana Elbourne; Matthias Egger; Douglas G Altman Journal: BMJ Date: 2010-03-23
Authors: Susan M McCurry; Michael Von Korff; Charles M Morin; Amy Cunningham; Kenneth C Pike; Manu Thakral; Robert Wellman; Kai Yeung; Weiwei Zhu; Michael V Vitiello Journal: Contemp Clin Trials Date: 2019-10-13 Impact factor: 2.226
Authors: Kelly M Shaffer; Fabian Camacho; Holly R Lord; Philip I Chow; Tonya Palermo; Emily Law; Frances P Thorndike; Karen S Ingersoll; Lee M Ritterband Journal: J Behav Med Date: 2019-05-31
Authors: Benjamin H Balderson; Susan M McCurry; Michael V Vitiello; Susan M Shortreed; Bruce D Rybarczyk; Francis J Keefe; Michael Von Korff Journal: Behav Sleep Med Date: 2015-10-20 Impact factor: 2.964
Authors: Michael T Smith; Patrick H Finan; Luis F Buenaver; Mercedes Robinson; Uzma Haque; Angela Quain; Erin McInrue; Dingfen Han; Jeannie Leoutsakis; Jennifer A Haythornthwaite Journal: Arthritis Rheumatol Date: 2015-05 Impact factor: 10.995
Authors: Hsin-Yi Jean Tang; Susan M McCurry; Kenneth C Pike; Michael Von Korff; Michael V Vitiello Journal: J Psychosom Res Date: 2017-07-01 Impact factor: 3.006
Authors: Erin Koffel; Kurt Kroenke; Matthew J Bair; David Leverty; Melissa A Polusny; Erin E Krebs Journal: Health Psychol Date: 2015-06-15 Impact factor: 4.267
Authors: Jack D Edinger; J Todd Arnedt; Suzanne M Bertisch; Colleen E Carney; John J Harrington; Kenneth L Lichstein; Michael J Sateia; Wendy M Troxel; Eric S Zhou; Uzma Kazmi; Jonathan L Heald; Jennifer L Martin Journal: J Clin Sleep Med Date: 2021-02-01 Impact factor: 4.062